Health management

5 March 2018 By Liam Proud

The German industrial group is selling a modest 15 pct of its Healthineers arm at a lower-than-expected 30 bln euro valuation. Siemens’ conservatism is partly because it doesn’t need the cash. But recent market ructions also make this the wrong time to be aggressive on pricing.

This content is for Subscribers only

To access full content you must be a subscriber. Please use the following link to request a trial.


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)